Latest Diasorin News & Updates

See the latest news and media coverage for Diasorin. We track all announcements, press releases, and industry mentions in real time, all in one place.

Diasorin

Manufacturer of immunodiagnostic and molecular diagnostic systems

diasorin.com

Headquarters: Saluggia, Italy
Company type: Public company
Number of employees: 2,500–5,000
Industry: Advanced Medical Equipment & Technology

Last updated Today

Latest news about Diasorin

In short: Diasorin expanded its diagnostic portfolio with several FDA clearances, launched a new 2026-2030 business plan, and appointed a new CFO.

Company announcements

July 31 Diasorin

Diasorin's H1 2026 revenue and EBITDA supported by strong Q2 growth

Revenue was €602 million, flat at CER, with adjusted EBITDA of €194 million (32% margin). 2026 guidance confirmed.

June 19 Diasorin

Diasorin receives FDA clearance and CLIA waiver for GAS assay

The assay runs on the LIAISON NES POC platform and delivers molecular results in 15 minutes.

May 20 Diasorin

Diasorin approves 2026-2030 business plan

The plan targets 4-6% CAGR revenue growth and 34-35% EBITDA margin by 2030, focusing on specialty diagnostics expansion.

May 19 Diasorin

Diasorin receives FDA clearance for gastrointestinal assay

The LIAISON PLEX Gastrointestinal Flex Assay detects 24 pathogens and is customizable.

Media coverage

July 31 Milano Finanza

Diasorin, net profit down 15% in the first half of 2026. Revenues above 600 million euros

The diagnostics company reports an improvement in the second quarter, with a 4% growth in turnover and a more contained slowdown in profits...

July 31 MSN

Diasorin beats estimates in the first half: revenues above expectations and guidance confirmed

Diasorin closes the first half of 2026 exceeding analysts' forecasts on revenues and profitability. Despite a slight decline on an annual basis related to the...

July 31 Il Sole 24 Ore

Diasorin: Rosa, clear impact from Middle East crisis, revenues zeroed in first half

Expected gap throughout 2026, but no effects from inflation (Il Sole 24 Ore Radiocor) - Milan, July 31 - 'We have found a clear impact...

July 31 la Repubblica

Diasorin, half-year profit falls to 84 million. Revenue recovering in the second quarter

The three months benefited from the strong performance of the US market, which has returned to sustained growth. China and the Gulf weigh...

Never miss news about Diasorin

Track Diasorin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Diasorin competitors & trending companies

Browse news for competitors to Diasorin and other trending companies.